Cyclezyme AB (XSAT:CYCLE) Debt-to-EBITDA : -0.34 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cyclezyme AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cyclezyme AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.04 Mil. Cyclezyme AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.46 Mil. Cyclezyme AB's annualized EBITDA for the quarter that ended in Dec. 2023 was kr-1.49 Mil. Cyclezyme AB's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.34.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cyclezyme AB's Debt-to-EBITDA or its related term are showing as below:

XSAT:CYCLE' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.34 Med: -0.17 Max: -0.01
Current: -0.34

During the past 4 years, the highest Debt-to-EBITDA Ratio of Cyclezyme AB was -0.01. The lowest was -0.34. And the median was -0.17.

XSAT:CYCLE's Debt-to-EBITDA is ranked worse than
100% of 1214 companies
in the Chemicals industry
Industry Median: 2.35 vs XSAT:CYCLE: -0.34

Cyclezyme AB Debt-to-EBITDA Historical Data

The historical data trend for Cyclezyme AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclezyme AB Debt-to-EBITDA Chart

Cyclezyme AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

-0.01

-0.34

Cyclezyme AB Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Debt-to-EBITDA	-	-	-0.01	-0.34

Competitive Comparison of Cyclezyme AB's Debt-to-EBITDA

For the Specialty Chemicals subindustry, Cyclezyme AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclezyme AB's Debt-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cyclezyme AB's Debt-to-EBITDA falls into.

Cyclezyme AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cyclezyme AB's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.042	+	0.458)	/	-1.492
	=	-0.34

Cyclezyme AB's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.042	+	0.458)	/	-1.492
	=	-0.34

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Dec. 2023) EBITDA data.

Cyclezyme AB (XSAT:CYCLE) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Cyclezyme AB Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cyclezyme AB's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclezyme AB (XSAT:CYCLE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cyclezyme AB (XSAT:CYCLE) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.cyclezyme.se

Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.

Cyclezyme AB (XSAT:CYCLE) Headlines

No Headlines